At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
T2769other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety Assessment of T2769 in Patients With Moderate to Severe Dry Eye Syndrome
In Brief
A clinical study evaluating T2769 for Dry Eye Syndrome. Completed, enrolled 62 participants across 3 sites.
Detailed Summary
Efficacy of T2769 in Dry Eye Desease
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
CountriesTunisia
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedFeb 2019
Primary CompletionFeb 2019
TodayJul 2026
First PostedFeb 5, 2019
Enrollment StartSep 1, 2018
Primary CompletionFeb 18, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.4 years ago
Interventions
T2769other
At least 55 enrolled patients for at least 50 evaluable patients treated by T2769 for 42 days